膵がんの治療の世界市場分析:影響を受ける部分別(外分泌、内分泌腺)、タイプ別(化学療法、標的療法、その他)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Approaches for Market Estimation
1.3.1 Approach 1: Demand analysis & bottom-up approach
1.3.2 Approach 2: Top-down market estimation
1.3.3 Approach 3: Commodity flow and bottom-up market estimation
1.3.4 Approach 4: KoL perspective-based market sizing
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Pancreatic Cancer Treatment Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.2 Market restraint analysis
3.3 Key Opportunities Prioritized
3.4 Industry Analysis Porter’s
3.5 PESTEL Analysis
Chapter 4 Pancreatic Cancer Treatment Market: Affected Region Estimates & Trend Analysis
4.1 Pancreatic Cancer Treatment Market: Affected Region Movement Analysis
4.2 Exocrine
4.2.1 Market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Endocrine
4.3.1 Market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis
5.1 Pancreatic Cancer Treatment Market: Treatment Movement Analysis
5.2 Chemotherapy
5.2.1 Market estimates and forecasts, 2014 – 2025 (USD Million)
5.3 Targeted Therapy
5.3.1 Market estimates and forecasts, 2014 – 2025 (USD Million)
5.4 Others
5.4.1 Market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6 Pancreatic Cancer Treatment Market: Regional Estimates & Trend Analysis, by Affected region & Application
6.1 Pancreatic Cancer Treatment Market Share by Region, 2015 & 2025
6.2 North America
6.2.1 U.S.
6.2.1.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.2.1.2 Market estimates and forecasts, by application, 2014 – 2025
6.2.2 Canada
6.2.2.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.2.2.2 Market estimates and forecasts, by application, 2014 – 2025
6.3 Europe
6.3.1 U.K.
6.3.1.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.3.1.2 Market estimates and forecasts, by application, 2014 – 2025
6.3.2 Germany
6.3.2.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.3.2.2 Market estimates and forecasts, by application, 2014 – 2025
6.4 Asia Pacific
6.4.1 China
6.4.1.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.4.1.2 Market estimates and forecasts, by application, 2014 – 2025
6.4.2 Japan
6.4.2.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.4.2.2 Market estimates and forecasts, by application, 2014 – 2025
6.5 Latin America
6.5.1 Brazil
6.5.1.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.5.1.2 Market estimates and forecasts, by application, 2014 – 2025
6.5.2 Mexico
6.5.2.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.5.2.2 Market estimates and forecasts, by application, 2014 – 2025
6.6 MEA
6.6.1 South Africa
6.6.1.1 Market estimates and forecasts, by affected region, 2014 – 2025
6.6.1.2 Market estimates and forecasts, by application, 2014 – 2025
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Company Profiles
7.2.1 Eli Lily and Company
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Product benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Celgene Corporation
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Product benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Hoffmann-La Roche AG
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Product benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Amgen, Inc.
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Product benchmarking
7.2.4.4 Strategic initiatives
7.2.5 Novartis AG
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Product benchmarking
7.2.5.4 Strategic initiatives
7.2.6 PharmaCyte Biotech, Inc.
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Product benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Clovis Oncology
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Product benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Teva Pharmaceutical Industries Ltd.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Product benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Merck & Co., Inc.
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Product benchmarking
7.2.9.4 Strategic initiatives
7.2.10 Pfizer, Inc.
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Product benchmarking
7.2.10.4 Strategic initiatives


【レポート販売概要】

■ タイトル:膵がんの治療の世界市場分析:影響を受ける部分別(外分泌、内分泌腺)、タイプ別(化学療法、標的療法、その他)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA)、セグメント予測、2014-2025
■ 英文:Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014-2025
■ 発行日:2017年2月13日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707634
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。